Yuezhen Wang

Dr. Yuezhen Wang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2022 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
YLYue Li
Yue Li
CLChong Li
Chong Li
YJYa Jiang
Ya Jiang
XHXue Han
Xue Han
SLSisi Liu
Sisi Liu
YWYuezhen Wang
Yuezhen Wang
Programmed cell death 1 ligand 1 (PD-L1) has been approved as predictive biomarker for non-small-cell lung cancer (NSCLC) patients treated with PD-(L)1 blockade therapy. The clinical/genomic features associated with PD-L1 are not well studied. Genomic profiling of tumor biopsies from 883 Chinese NSCLC patients was performed by targeted next-generation sequencing. Immunohistochemical analysis was conducted to evaluate PD-L1 expression levels using antibodies Dako 22C3 and 28-8, respectively. Our study showed distinct correlation between PD-L1 expression and clinical/genomic characteristics when using different PD-L1 antibodies and in different histological subtypes including adenocarcinoma (ADC) and squamous cell carcinoma (SCC), respectively. PD-L1 high expression (22C3) was associated with male and lymph node metastasis only in ADC patients. Furthermore, mutations of TP53 and KRAS, KIF5B-RET fusion, copy number gains of PD-L1 and PD-L2, and arm-level amplifications of chr.12p were significantly associated with PD-L1 positive status in ADC patients. For SCC patients, the gain of EGFR and MDM2 and loss of PTPRD were negatively associated with PD-L1 expression. We also compared our results with other studies and found conflicting results presumably because of the multiplicity of antibody clones and platforms, the difference of cutoffs for assigning PD-L1 expression levels, and the variation in study populations. Our study can help to understand the utility and validity of PD-L1 as biomarker of response to immune checkpoint inhibitors.

1 January 2022 in Journal of Physics: Conference Series
Verified
Conference Paper
Open access
YWYuezhen Wang
Yuezhen Wang
ZLZhifeng Liu
Zhifeng Liu
YLYing Li
Ying Li
CYCongbin Yang
Congbin Yang
The bolted-flange connection is one of the most popular detachable mechanical joints in mechanical flange connection. It is well known that bolted-flange joints need to be tightened to meet the assembly performance in practical engineering applications. However, the dispersion of the pre-tightening force caused by the elastic interaction between the bolts has a serious impact on the sealing and safety of the product, and therefore the optimization of bolt preload has always been a hot spot in the assembly research field. Combining mathematical theory and experimental data, this paper proposes an optimization model for uniformly distributed preload based on the Markov theory. The torque method was utilized to fasten the bolt-flange joint. The bolt pre-tightening force in the final state was collected and used as sample data. A state transition model was constructed to determine the state transition matrix. Ultimately, an iterative model of the preload was deduced, and the rationality of the model was verified through experimentation. The proposed optimization method of bolt preload can be applied to determine the initial preload of each bolt. This method improves the assembly efficiency and accuracy, which provides a theoretical approach to effectively guide the tightening work of bolted-flange connections.